Solvay Pharmaceuticals CEO Dodd joins from Wyeth; Mahady named Wyeth pharmaceuticals president.

SOLVAY PHARMACEUTICALS CEO IS EX-WYETH EXEC DODD, who was named to head Solvay's U.S. Pharmaceuticals business Aug. 17. David Dodd, 45, was previously Wyeth-Ayerst senior VP-pharmaceutical products. He succeeds James Warren, PhD, who left Solvay in March for an academic position. Solvay Senior VP-Sales & Marketing Laurence Downey, MD, had been acting as interim CEO.